Global Medical REIT Inc Stock News

Armada Hoffler, Easterly Government Properties, and Global Medical REIT trade at deep NAV discounts and low FFO multiples after dividend cuts. AHH, DEA, and GMRE offer 8.5%–9% yields and 60%–125% potential capital appreciation if multiples revert to REIT averages. Tax-loss selling and AI-driven market rotation have intensified REIT discounts, creating unusually attractive entry points for value...

Global Medical REIT is rated a buy, driven by strong AFFO growth, robust dividend coverage, and sector tailwinds. GMRE redeploys capital into higher cap-rate assets, maintains low tenant concentration risk, and benefits from geographic diversification including presence in high-growth regions like Texas and Florida. Despite elevated leverage (D/E 1.50), GMRE's forward P/FFO of 8.6 is 35% below ...

We are in the midst of the biggest retail sales period of the year. Yet, investors are skeptical about bargains in the stock market. Buy a bigger income stream at cheaper prices. We discuss our top defensive picks with up to 8% yields.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Boar...

Global Medical REIT Inc. has launched its 8.00% Series B Cumulative Redeemable Preferred Stock GMRE.PR.B, targeting high-yield seeking investors. GMRE-B offers a high yield but is considered highly speculative, with no credit rating and a risk profile similar to Single-B rated debt. Recent red flags for GMRE include a reverse stock split, a dividend cut, and a debt-heavy capital structure, warr...

I invest most of my capital in REITs. Even then, I'm bearish on a lot of them. This is a sector in which you need to be very selective to succeed.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expect...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the commencement of an underwritten public offering of shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”), subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase addition...